|
Re: Resverlogix Highlights Unique Properties of Apabetalone in Both a Rare Muscular Dystrophy (FSHD) and Neurodegenerative Eye Disease
|
5
|
Resverlogix Corp.
|
Feb 13, 2017 10:41AM
|
|
Re: NIH Halts Large Cardiovascular Inflammation Reduction Trial (CIRT)
|
5
|
Resverlogix Corp.
|
Sep 24, 2018 03:23PM
|
|
Re: Friedreich’s Ataxia Therapy News - Very interesting
|
5
|
Resverlogix Corp.
|
May 26, 2017 10:21AM
|
|
Re: The final events.....
|
5
|
Resverlogix Corp.
|
Jan 26, 2019 04:23PM
|
|
Re: News,
|
5
|
Resverlogix Corp.
|
Jun 27, 2019 04:10PM
|
|
Re: Finally got around to this. UN-official, of course
|
5
|
Resverlogix Corp.
|
Sep 16, 2015 11:12PM
|
|
American Society for Nephrology abstract to be presented 11/18
|
5
|
Resverlogix Corp.
|
Nov 11, 2016 04:30PM
|
|
Re: Notes from the Zenith Corporate Update
|
5
|
Zenith Epigenetics
|
Dec 16, 2016 11:41AM
|
|
Re: Gordon Research Conference Presentation Thursday June 14th
|
5
|
Resverlogix Corp.
|
Jun 13, 2018 07:53PM
|
|
Re: Where are we
|
5
|
Resverlogix Corp.
|
May 05, 2017 10:20AM
|
|
Re: Layperson explanation
|
5
|
Resverlogix Corp.
|
Jun 12, 2019 08:52PM
|
|
Re: An ESC video.....A Question for anyone who knows....
|
5
|
Resverlogix Corp.
|
Sep 09, 2019 10:31PM
|
|
Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
5
|
Resverlogix Corp.
|
Dec 22, 2020 07:47AM
|
|
Re: Bear
|
5
|
Resverlogix Corp.
|
Jan 28, 2016 11:58AM
|
|
AHA 2018 Resverlogix Poster #1
|
5
|
Resverlogix Corp.
|
Nov 11, 2018 03:17PM
|
|
Re: AACR
|
5
|
Zenith Epigenetics
|
Mar 31, 2019 08:05AM
|
|
Re: Zenith poster from AACR EORTC meeting and Annual General/Special meeting date
|
5
|
Resverlogix Corp.
|
Nov 13, 2015 04:37PM
|
|
Re: AEGIS-II trial
|
5
|
Resverlogix Corp.
|
Mar 22, 2018 08:20PM
|
|
Re: Coronary Artery Calcium Score
|
5
|
Resverlogix Corp.
|
Feb 18, 2019 11:22AM
|
|
Re: AGM Sept. 12, 2018
|
5
|
Zenith Epigenetics
|
Jun 30, 2018 10:59AM
|
